Status:
COMPLETED
Study of Immunity Dysfunction Induced by Extracorporeal Assistance (ECMO / ECLS)
Lead Sponsor:
Rennes University Hospital
Conditions:
Acute Respiratory Distress Syndrome
Cardiogenic Shock
Eligibility:
All Genders
18+ years
Brief Summary
Study of immunosuppression biomarkers in patients with ARDS or cardiogenic shock with ECMO / ECLS, compared to patients with ARDS or cardiogenic shock without ECMO / ECLS
Eligibility Criteria
Inclusion
- Patient older than 18 years old
- Patient hospitalized in an intensive care unit
- Patient whose initial ARDS or Cardiogenic shock began less than 5 days before admission
- Patients hospitalized for ARDS or Cardiogenic shock with ECMO / ECLS or - Patients hospitalized for ARDS or Cardiogenic shock without ECMO / ECLS
Exclusion
- Opposition of patient, relative or legal representative for participation in the study
- Pregnant woman
- Pre-immunodepression
- Implementation of immunosuppressive therapy such as chemotherapy, cyclophosphamide, high-dose corticosteroids (\> 0.5mg / kg / day).
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2019
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03262155
Start Date
January 1 2017
End Date
January 31 2019
Last Update
April 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Rennes
Rennes, France, 35033